key: cord-0305182-a5lqd0n5
authors: Schmitz, D.; Ek, W. E.; Berggren, E.; Höglund, J.; Karlsson, T.; Johansson, A.
title: Genome-Wide Association Study of Estradiol Levels, and the Causal Effect of Estradiol on Bone Mineral Density
date: 2021-07-05
journal: nan
DOI: 10.1101/2021.07.01.21259826
sha: a42e293ab1559769e03f716c48dc965a576d1f98
doc_id: 305182
cord_uid: a5lqd0n5

Context. Estradiol is the primary female sex hormone and plays an important role for skeletal health in both sexes. Several enzymes are involved in estradiol metabolism but few genome-wide association studies (GWAS) have been performed to characterize the genetic contribution to variation in estrogen levels. Objective. Identify genetic loci affecting estradiol levels and estimate causal effect of estradiol on bone mineral density (BMD). Design. We performed GWAS for estradiol in males (N = 147,690) and females (N = 163,985) from UK Biobank (UKB). Estradiol was analyzed as a binary phenotype; above/below detection limit (175 pmol/L). We further estimated the causal effect of estradiol on BMD using Mendelian randomization. Results. We identified 14 independent loci associated (P<5x10-8) with estradiol levels in males, of which one (CYP3A7) was genome-wide and seven nominally (P<0.05) significant in females. In addition, one female specific locus was identified. Most loci contain functionally relevant genes that have not been discussed in relation to estradiol levels in previous GWAS. For example, SRD5A2, which encodes a steroid 5-alpha reductase that is involved in processing androgens, and UGT3A1 and UGT2B7 which encode enzymes likely to be involved in estradiol elimination. The allele that tags the O blood group, at the ABO locus, was associated with higher estradiol levels. We identified a causal effect of high estradiol levels on increased BMD in both males (P=1.58x10-11) and females (P=7.48x10-6). Conclusion. Our findings further support the importance of the body's own estrogen to maintain skeletal health in males and in females.

contained a total of 93,093,070 SNPs. We only analyzed SNPs with minor allele frequency 113 (MAF) > 0.01, and removed SNPs deviating from Hardy-Weinberg (P-value < 1x10 -20 ) and 114 markers with more than 5% missing genotype data, and with imputation quality < 0.3. After 115 quality control (QC), a total of 7,651,231 autosomal SNPs, and 220,486 SNPs on the X-116 chromosome remained. We included Caucasian participants clustering with regards to their 117 genetic principal components. We also excluded first-and second-degree relatives (genetic 118 relationship > 0.044), using kinship data. Samples with sex discordance, high 119 heterozygosity/missingness, and with more than 5% missing genotypes were also excluded. 120

After QC and exclusion, 361,975 unrelated Caucasian participants remained (167,168 males 121 and 194,807 females). 122

123 Estradiol had been measured by two step competitive analysis on a Beckman Coulter Unicel 124 Dxl 800. We only included measurements from the blood samples that were collected during 125 7 oral contraceptive use (current, ever or never), number of live births, menopausal status and 137 whether they have undergone hysterectomy, were also included. Women who were unsure 138 about menopausal status were excluded. For this study, we applied a P-value threshold of 139 5x10 -8 , which is commonly used in GWAS when using a MAF cutoff of 1% 21 , and 140 corresponds to a correction of 1 million independent tests (SNPs). Manhattan plots were 141 generated using the R package hudson. We applied the clump-function in PLINK 1.90 to 142 define start and end positions for each locus with the main parameters that determines the 143 clumping being set to: R 2 =0.1, p1=5x10 -8 and p2=1x10 -4 . We subsequently performed 144 conditional analyses for each locus, conditioning on the SNP with the lowest P-value from 145 each locus. If there was any significant conditional SNP, this was repeated by also 146 conditioning on the conditional SNP from the previous analyses, until no additional 147 significant associations remained. 148

Several sensitivity analyses were performed for the GWAS. First, we stratified females into 149 being pre-and postmenopausal. Secondly, we excluded all participants with a cancer 150 diagnosis prior to assessment (when blood samples were taken). Finally, we also analyzed 151 males and females with testosterone and sex hormone-binding globulin (SHBG) levels 152 included as covariates, in addition to the other covariates and with age at menopause as a 153 covariate in the female postmenopausal stratum. 154

To identify likely target genes for the associated variants, we first identified genes containing 156 the lead SNPs, or the closest gene(s) for each individual lead SNP. We also used HaploReg 157 v4.1 22 to identify potential functional effects by the individual lead SNP, or any variant in 158 linkage disequilibrium (LD, R 2 >0.8) with the lead SNP. We then checked for overlap 159 between the lead SNPs and expression quantitative trait loci (eQTL) using data from the 160 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint Genotype-Tissue Expression (GTEx) project 23 . We considered our lead SNP to overlap with 161 an eQTL if our lead SNP was in LD (R 2 >0.8) with a lead SNP for an eQTL. To identify 162 overlap with other phenotypes from previously published GWAS we downloaded summary 163 statistics from the GWAS catalog (Version downloaded: 1.0.3, date: 2020-11-13). We 164 defined signals to be overlapping if a lead SNP from a previous GWAS was in LD (R 2 >0.8) 165

with any of our lead SNPs. 166

167 Firstly, we undertook a one-sample MR approach to investigate the causal effect of estradiol 168 on BMD in UKB, in males and females separately. BMD was measured as heel BMD, based 169 on an ultrasound measurement of the calcaneus (heel bone), using the Sahara Clinical Bone 170

Sonometer. We used T-score, automated (data-field 78 in UKB). The T-score is the number 171 of standard deviations a person's BMD differs from the mean BMD of their respective sex. 172

The main MR analyses were performed with the R package gsmr (version 1.0.8) 24 . The 173 weighted median method is estimated using bootstrapping. If heterogeneity is present in the 186 data, these methods would tend to show higher p-values as compared GSMR, as GSMR is 187 expected to remove outliers. Secondly, the MR results were further replicated by two-sample 188 MR, using the GWAS summary statistics for BMD from the GEFOS study 26 . This was done 189 in order to avoid any weak-instrument bias towards the confounded association, potentially 190 present in one-sample MR analyses. We used GWAS summary statistics for lumbar spine 191 BMD (LSBMD) from the 2012 data release on www.gefos.org (downloaded: 2020-11-13), 192 which was the only dataset with summary statistics for males and females separately that did 193 not include samples from UKB. The two sets (for males and females) of genetic variants that 194 had been selected in UKB were tested independently using GEFOS BMD summary statistics 195 for males and females respectively. The overlap, with regards to SNPs, was not perfect 196 between UKB and GEFOS. We therefore revised the set of SNPs for the MR in GEFOS 197 slightly. For each of our GWAS locus, we selected the most significant SNP in LD with our 198 lead SNP (" ! > 0.3) for which summary statistics were also available in the GEFOS data as 199 a proxy. However, to avoid too weak instruments in the MR, only proxies that were 200 associated with estradiol levels (P< 0.0001) were included in the MR. Finally, we note that 201 any winner's-curse bias in our effect estimates of the genetic variants associated with 202 estradiol levels, should, on average, drive the estimates of the causal effect of estrogen on 203 BMD towards the null. 204

A total of 147,690 male participants had passed our genotype and estradiol QC (Figure 1 , 206 Table 1 ). Of these, 134,323 had estradiol levels below detection limit (175 pmol/L), while 207 13,367 individuals had measured estradiol levels above, or equal to 175 pmol/L (Table 1) . 208

The number of females (N = 163,985) was slightly higher compared to males, with 37,461 209 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint having estradiol levels above detection limit, and 126,524 below. Dramatically smaller 210 fractions of males (9.1%) and postmenopausal women (7.9%) had detectable estrogen levels 211 (Table 1) , in comparison to the fraction of premenopausal women (71.9%) with detectable 212 estrogen levels. Number of live births, age, and BMI were significantly lower among women 213 with detectable estradiol in both post and premenopausal strata (P<0.05). 214

We identified 15 loci, on 14 different chromosomes, to be significantly associated (P<5x10 -8 ) 216 with estradiol in males or females ( Figure 2 , Table 2 ). Of these, 13 were genome-wide 217 significant only in males, one only in females (MCM8) and one in both males and females 218 (CYP3A7). On chromosome 2, and 15, one conditional SNP was identified per locus, located 219 in the vicinity to the primary lead SNPs (Table 2) . Among the lead SNPs identified in males, 220 some were located in or close to genes with a well-known role in estradiol metabolism. 221

Among the most significant loci, we found FAM9A and CYP19A1, which have previously 222 been identified in GWAS for estradiol in males 12,15 . One lead SNP, rs45446698, was 223 genome-wide significant in both males and females, mapped to CYP3A7. It is also the most 224 significant eQTL for CYP3A7 in adrenal gland in GTEx (P=1.2x10 -12 ), suggesting that the 225 effect is mediated by the expression level of CYP3A7. The minor (G) allele increases the 226 level of CYP3A7 expression, but decreases the estradiol levels. There was also one lead SNP 227 in SHBG, which codes for SHBG that had been linked to measurements of several other sex 228 hormones 16 . Another lead SNP was located on the X chromosome, within the AR gene that 229 encodes an androgen receptor. We also found a very strong association on chromosome 2, 230 that overlaps with SRD5A2, which codes for 3-oxo-5-alpha-steroid 4-dehydrogenase 2, 231 known to catalyze the conversion of testosterone into androgen or dihydrotestosterone 27 . Our 232 most significant SNP is in LD (R 2 =0.75) with rs9282858, which is a missense variant that is 233 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 5, 2021.

predicted to be deleterious (SIFT=0.03). Here, the minor allele was associated with higher 234 estradiol levels (Table 2) . At the same locus on chromosome two, there was also one strong 235 conditional signal, further upstream of the primary signal, closer to MEMO1. 236

There was also an association to rs657152 in ABO, and SNP that is in LD (R 2 =0.98) with 237 rs8176719, which tags the O blood group 28 . The A allele of rs657152 (Table 2) CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint multiple types of cancer 33,34 . A third SNP was a missense variant in LINC01324, a lncRNA 258 which has been established as a predictor for melanoma progression 35 . 259

The lead SNP that was only significant in females (rs16991615, Table 2 ), is a missense 260 variant located in MCM8. MCM8 codes for a DNA helicase, which is involved in the repair 261 of double-stranded DNA breaks and recombination 36 . Even though very few genome-wide 262 significant SNPs were identified in women, eight out of 14 of the loci that were genome-wide 263 significant in males, were at least nominally associated in females as well (P < 0.05), and 264 with the same direction of effect ( Figure 3 ). Especially the genes with functions related to 265 hormone metabolism; UGT2B7, UGT3A1, CYP3A7, CYP19A1, SRD5A2, and SHBG 266 replicated in females, but also IGHV3-7 and ABO. 267

Even though the primary aim of the sensitivity analyses was to further verify the associations 269 from the primary GWAS, we did perform GWAS with the different sets of covariates/strata 270 in the sensitivity analyses as well. However, no additional genome-wide significant locus was 271 identified. The effects of the findings from the primary analyses changed somewhat. When 272 stratifying females into pre-and post-menopause there was one locus, CYP3A7, with a 273 significant difference in the OR between the two strata (Supplementary Table S1 After removing all participants that had a prior cancer diagnosis at the time of assessment, 278 there was no significant difference in OR compared to the primary GWAS, and all lead SNPs 279 were still genome-wide significant, indicating that a prior cancer diagnosis did not influence 280 our primary results (Supplementary Table S1 37 ). However, when adjusting the estradiol 281 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint GWAS for testosterone and SHBG levels, the lead SNPs at SHBG and FKBP4 were no 282 longer genome-wide significant in males, and the corresponding effects were significantly 283 lower than the previous signals. Also, for UGT3A1 and AR, the P-values were below the 284 threshold for genome-wide significance for estradiol when adjusting for testosterone and 285 SHBG levels, but the ORs were not significantly different from the primary analyses. This 286 indicates that the signals at SHBG and FKBP4 might have been completely driven by SHBG 287 and testosterone levels, whereas the other loci are more likely to be estradiol specific loci. We 288 observed the same effect for the female-specific locus MCM8. There was no significant 289 difference in OR between the primary GWAS in postmenopausal women with and without 290 adjustment for age at menopause, suggesting that the results in females are not strongly 291 confounded by age at menopause as has been discussed previously 16 . 292

We did a systematic check for overlap with previous GWAS results that were available in the 294 GWAS catalog (Supplementary Table S2 results from over 100 GWAS, with associations to metabolites, liver enzymes and proteins as 306 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. Figure 4a ). As estradiol was analyzed as a binary phenotype, the unit for the 329 estimate from the MR can be interpreted as standard units increase in T-score associated with 330 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint having estradiol levels above detection limit. Similar MR results were obtained using 331 weighted median and MR-Egger, which do not remove pleiotropic SNPs. The MR-Egger 332 intercept was not significantly different from zero, indicating that these results are not 333 strongly influenced by directional pleiotropy. 334

To get a reasonable number of instruments to be used for the MR analysis in females, we 335 used a less strict P-value cutoff (P<1x10 -7 ), resulting in a total of 4 instrumental variables 336

(Supplementary Table S3 37 ) that were included in the analysis. In the GSMR analyses, the 337 HEIDI-outlier flag was disabled in females, as there were fewer (<10) SNPs than 338 recommended for this approach to work properly 24 . We identified a causal effect of high 339 estradiol levels on BMD also in women (β=0.03, P=7.48x10 -6 , Figure 4b ). All three 340 alternative MR methods showed the same direction of effect, although the null hypothesis of 341 no effect could not be rejected, and the MR egger intercept was not significantly different 342 from zero (Table 3) . 343

To further validate the MR results we also did a two-sample MR for males and females 344 respectively using the instruments selected for estradiol in UKB and the GWAS summary 345 statistics from the BMD GWAS in GEFOS 26 . A slightly different set of instrumental 346 variables (Supplementary Table S3 Previous concerns that age at menopause influences estradiol levels, could potentially render 352 some of our selected instruments invalid since being affected by confounding (correlated 353 horizontal) pleiotropy. We therefore also performed a third set of MR-analyses in females. 354 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint

Here, we selected the instruments for estradiol from the GWAS in males, which should not 355 be influenced by age at menopause. To reduce the risk for male-specific effects on estradiol 356 levels, we filtered for SNPs that were significant also in females, after adjusting for the 16 357 instruments tested (P<0.0031), resulting in six instruments and used the estradiol estimates 358 for females in UKB (Supplementary Table S3 37 ). Using the GSMR approach, we could 359 identify a significant effect on BMD in females, similar to the effect estimated in males 360 (β=0.16, P=4.97x10 -6 (Table 3, Figure 4e ). These results indicate that the effect in females is 361 not driven by age at menopause. 362

We have presented results from a large GWAS for estradiol levels in males and females. 364

Many of the significant SNPs are annotated to genes with functions that are biologically 365 relevant to estrogen metabolism. For example, by converting and transporting androgen and 366 endogens, synthesis or elimination of steroid hormones. In males, we identified 14 loci, to be 367 associated with serum estradiol levels, and another two independent SNPs on chromosome 2 368 and 15. In females, we identified two significant loci. One locus, within the CYP3A7 gene, 369 overlaps with our findings in males, but the other locus, mapping to MCM8, was specific to 370 females. However, a majority (eight) of the male loci, was at least nominally significant in 371 females, even if the estimated effect size was lower. These results suggest that genetic effects 372 on estradiol levels might differ between males and females. However, in premenopausal 373 women, estradiol levels vary during the menstrual cycle, limiting our ability to estimate the 374 genetic effects on estradiol in females. In postmenopausal women, on the other hand, 375 estradiol levels drop rapidly, and it has previously been suggested that the estradiol levels in 376 females are more likely to be determined by the number of years since menopause 39 . For 377 those reasons, we performed sensitivity analyses, stratifying females by menopausal status, 378 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint and also adjusting for age at menopause in the postmenopausal strata. The only locus being 379 significantly different between pre-and postmenopausal women was CYP3A7. The largest 380 effect was seen in postmenopausal women, followed by males, and then premenopausal 381 women. CYP3A7 encodes cytochrome P450 CYP3A7, which metabolizes 382 dehydroepiandrosterone (DHEA), a precursor of both androgen and estrogen synthesis, and 383

shows catalytic activity for conversion of estrone to hydroxyestrogens 40,41 . As much as 75% 384 of the circulating estrogens in premenopausal women and 50% of circulating androgens in 385 men are known to be derived from DHEA. After menopause, DHEA is thought to be the 386 major precursor of androgens and estrogens in females 42 . Interestingly, the effect of the 387 CYP3A7 SNP disappeared when adjusting for SHBG and testosterone levels in females, but 388 the effect was unaffected in males. However, CYP3A7 loses genome-wide significance when 389 adjusting for testosterone levels. This suggests that CYP3A7 might have different functions in 390 males and in females, as well as in pre-and in postmenopausal women. In postmenopausal 391 women CYP3A7 appears to mainly influence estradiol levels by regulating the amount of 392 available testosterone as a precursor for estrogen. 393

Several other loci, with previous links to estrogen metabolism were also identified. SULT2A1 394 encodes a sulfotransferase which are active on hydroxylated steroid hormones and bile 395 acids 30 . Sulfotransferase 2A1, encoded by SULT2A1, mediates the sulfation of a wide range 396 of steroids and sterols, including DHEA, a precursor of estrogen and testosterone. SULT2A1 397 was only associated with estradiol in males, and this association was similar (slightly 398 stronger) when adjusting for testosterone and SHBG levels. Two of the most well-known 399 loci, that has previously also been associated with estradiol in males in GWAS, are FAM9A 400 and CYP19A1 12,15 . Aromatase, encoded by CYP19A1, is a key enzyme in the synthesis of 401 estradiol and estrone from testosterone and androstenedione, respectively 43 . The association 402

to CYP19A1 was at least nominally significant, in both the pre-and postmenopausal women, 403 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint as well as in all sensitivity analyses. The P-values were even numerically slightly lower when 404 adjusting for SHBG and testosterone, which agrees with the function of the protein. FAM9A 405 is exclusively expressed in testis 59 and it is therefore not surprising that there was no 406 association to FAM9A in females. Previously, FAM9A has also been associated with 407 testosterone levels 15 , and our analyses indicates that the association was partly driven by 408 associations to testosterone or SHBG levels. We could therefore conclude that the SNP at 409

FAM9A is likely to affect both testosterone and estrogen metabolism. This signal also 410 overlaps with a GWAS signal for male pattern baldness 38 , which further supports the 411 importance of this locus. However, FAM9A, encodes the protein FAM9A, that has a rather 412 unknown function. Also, the SNP is located between FAM9A and FAM9B and the annotation 413 of this locus should therefore be interpreted with care. 414

We identified a strong association between estradiol levels and the SHBG locus. The SHBG 415 gene encodes SHBG that has been linked to measurements of several other sex hormones 416 previously 16 . SHBG is a glycoprotein that binds to sex hormones, including testosterone and 417 estrogen, in the bloodstream, and thereby regulates the amount of bioavailable hormones 44 . 418

Only 1-2% of sex hormones are unbound and therefore bioavailable 45-47 . The association to 419 SHBG in males, completely disappeared after adjusting for SHBG levels. In females, there 420 was a nominally significant association to SHBG in the primary GWAS, with the same 421 direction of effect as in males. Interestingly, after adjusting for SHBG and testosterone levels, 422 there was still an association (P=0.00033), but the effect was in the opposite direction. 423

Similarly, an opposite effect between males and females has previously been seen for total 424 testosterone, where there is a negative genetic correlation between total testosterone and 425 SHBG in females, but a positive correlation in males 16 . This clearly illustrates the 426 heterogenous effects between males and females for sex hormones. We also identified two 427 associations to the X chromosome in males, one mapping to the AR gene, which encodes the 428 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint androgen receptor. In mammals, the action of androgens acts through this single androgen 429 receptor. In different tissues, the androgen receptor is activated by testosterone, or 430 testosterone is first converted into dihydrotestosterone which is then the activating 431 molecule 48 . Therefore, the androgen receptor plays an important role in sex differentiation, 432 mainly through regulating gene expression 49 . Interestingly no association (P>0.05) was seen 433 in females which might be due to the much lower levels of androgens in females. We also 434 found an association to SRD5A2 which encodes 3-oxo-5-ɑ-steroid 4-dehydrogenase 2 and is 435 located on chromosome 2. This enzyme catalyzes the conversion of testosterone to 5-ɑ-436 dihydrogentestosterone 27 . Thus, the variant in SRD5A2 might influence estradiol levels in 437 men by affecting the amount of testosterone available for conversion to estradiol. The SNP in 438 SRD5A2 is nominally significant in females, an association that is more pronounced in 439 postmenopausal women. There is also a conditional signal in males, 200 kb upstream, close 440 to MEMO1 which encodes the mediator of ErbB2-driven cell motility 1 (MEMO1). In 441 previous studies, it has been shown that MEMO1 regulates the extranuclear function of the 442 estradiol receptor 50 , which is a possible link to estradiol levels. It is therefore possible that the 443 GWAS signal on chromosome two, indeed represent associations with two different genes. 444

Another interesting association is with FKBP4, which encodes FKBP52 (FK506-binding 445 protein 4). FKBP52 has been show to regulate the androgen, glucocorticoid and progesterone 446 receptor signaling pathways 31 , by playing an important role in the formation of steroid 447 hormone nuclear receptors 51 . FKBP4 has been shown to regulate androgen receptor 448 transactivation activity and also been linked to testosterone levels 52 . When adjusting for 449 testosterone and SHBG levels, the FKBP4 association was weaker, and no longer significant. 450 451 Two loci, mapping to UGT2B7 and UGT3A1 were also identified. These two loci encode 452 UDP-glycosyltransferases, which are responsible for the addition of sugars to a broad range 453 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. has been suggested to be explained by modulation of sialic acid-containing receptors 472 distributed on host cell surface 58 . Covid-19 has a higher mortality in males, which has been 473 suggested to be linked to their lower estrogen levels 59,60 . We also identified several loci with 474 less clear links to estrogen metabolism including LINC01324, IGHV3-7, RBBP8, and MCM8. 475

MCM8 is the female-specific locus, where the lead SNP is a missense variant. Genetic 476 variants in MCM8 have previously been associated with premature ovarian failure 61,62 , a 477 condition that is characterized by low estrogen levels 51 . According to GTEx, MCM8 is highly 478 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint expressed in both female and male reproductive organs, despite only being significant in the 479 female GWAS cohort, which further support this locus as being involved in sex hormone 480 metabolism. 481

We also performed MR analysis and estimated a causal effect of estradiol on BMD in males, 482 and to our knowledge, for the first time also in females. Compared to previous studies in 483 males, with not more than five SNPs as instruments for estradiol 17 , we included as many as 484 16 SNPs in males and four in females. Interestingly, the effect estimate was higher for 485 females than males in the two-sample MR, which could agree with the fact that BMD 486 decreases more rapidly in females by age. Estrogen can be used as a preventative treatment in 487 postmenopausal women with low BMD 63,64 , to prevent osteoporosis, and our results were 488 therefore not surprising. However, one concern that has been raised previously 16 , is that 489 estradiol levels are driven by number of years till/from menopause. To reduce potential bias 490 in our results due to instruments being associated with age at menopause, we applied a 491 second approach where we used instruments from males, to minimize our instruments' 492 association to age at menopause. Using these instruments, we could replicate the MR results 493 in women which suggests that age at menopause is not dramatically influencing our results. 494 495 One of the major strengths of this study is the large cohort from UKB with estradiol 496 measurements available. However, only a subset of the participants had estradiol levels above 497 detection limit. To increase the number of participants to analyze, we created a binary 498 phenotype. Since normal levels of estradiol in males and postmenopausal women have a 499 range below or just above the detection limit, we were not able to capture the full spectrum of 500 individual variation in the cohort. Also, very few loci were identified in females. This could 501 be due to hormone levels fluctuating during the menstrual cycle lowering the power to 502 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint identify true genetic effects behind estradiol levels in premenopausal women. However, we 503 also conducted a GWAS including only women that had entered menopause, which should 504

give a more stable phenotype. However, no additional significant GWAS hits were identified, 505 even if the number of participants in the GWAS was comparable to the GWAS in males, and 506 the range of estradiol levels was comparable. This suggest that there is an underlying 507 difference in genetic effects between sexes. 508

In summary, we have identified biologically relevant genetic loci associated with variation in 509 estradiol levels in males and females and found differences in genetic effects between sexes. 510

In addition, we used an MR approach to show that estradiol levels have a causal effect on 511 good bone health in both males in females, confirming that estrogen replacement therapy may 512 be a good treatment to prevent osteoporosis and prevent fractures in elderly of both sexes. 513

Our findings support previous research on the synthesis of estradiol and its effects on bone 514 mineral density, as well as provide new insights into the genetic components of estrogen 515 regulation and metabolism. 516

The data used for this study is available for bona fide researchers from the UK Biobank 528

Resource (http://www.ukbiobank.ac.uk/about-biobank-uk/), and can be accessed by an 529 application to the UK Biobank. GEFOS data included in this study can be downloaded from 530 http://www.gefos.org. 531

Author contribu.ons . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 5, 2021. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 5, 2021. ; https://doi.org/10.1101/2021.07.01.21259826 doi: medRxiv preprint 

Physiology of the female reproductive axis

A role for oestrogens in the male reproductive 543 system

The structural biology of oestrogen metabolism

Causal associations between risk factors and common 606 diseases inferred from GWAS summary data

Interpreting findings from Mendelian randomization using 609 the MR-Egger method

Genome-wide meta-analysis identifies 611 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Biochemical and pharmacogenetic 614 dissection of human steroid 5α-reductase type II

Extensive polymorphism of ABO blood 617 group gene: Three major lineages of the alleles for the common ABO phenotypes

Receptor Function By the 52-kDa FK506-Binding Protein (FKBP52)

Nuclear localization and cell cycle-specific expression of CtIP, a 630 protein that associates with the BRCA1 tumor suppressor

Characterization of a carboxy-terminal 633 BRCA1 interacting protein

CtIP silencing as a novel mechanism of tamoxifen 636 resistance in breast cancer

A six-long non-coding RNA signature predicts prognosis in 639 melanoma patients

Baseline estrogen levels in postmenopausal 651 women participating in the MAP.3 breast cancer chemoprevention trial

Lippincott Williams and Wilkins

Human Cytochrome P450 3A7 Has a Distinct High 655

Catalytic Activity for the 16α-Hydroxylation of Estrone but not 17β-Estradiol. Cancer

Differential catalytic properties in metabolism 659 of endogenous and exogenous substrates among CYP3A enzymes expressed in COS

Minireview: Aromatase and the Regulation of Estrogen 663

circulating sex hormone-binding globulin reveals multiple loci implicated in sex 672 steroid hormone regulation

Transport of steroid hormones: Binding of 21 677 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding 678 globulin in human plasma

Androgen physiology

Biological actions of androgens

Mediator of ERBB2-driven cell motility (MEMO)

Cloning and expression of human liver UDP-695 glucuronosyltransferase cDNA, UDPGTh2

Glucuronidation of estrone and 16α-698 hydroxyestrone by human UGT enzymes: The key roles of UGT1A10 and UGT2B7

ABO Blood Groups and Cardiovascular Diseases

Interaction between oral estrogen 703 plus progestogen therapy and ABO blood groups on coagulation activation in 704 postmenopausal women

A quantitative difference in the activity of blood group A-707 specific N-acetylgalactosaminyltransferase in serum from A 1 and A 2 human subjects

Molecular mechanisms of sex bias differences 717 in COVID-19 mortality

Exome sequencing reveals MCM8 719 mutation underlies ovarian failure and chromosomal instability

Minichromosome maintenance 722 complex component 8 mutations cause primary ovarian insufficiency

Treatment of postmenopausal 725 osteoporosis with transdermal estrogen

Age at menarche, median (Q1 -Q3)* NA NA 12

Age at menopause, median (Q1 -Q3)* NA NA

Q1: 1 st quartile

Q3: 3 rd quartile

Bold cells are significantly (P < 0.05) associated with binary estradiol phenotype

*: Tested with Student's t-test

Tested with Fisher's exact test

These are the actual number of participants analyzed in the GWAS